Overexpression of EGR-1 modulates the activity of NF-κB and AP-1 in prostate carcinoma PC-3 and LNCaP cell lines

International Journal of Oncology

Volumn 39, Issue 2, 2011, Pages 345-352

  Parra Villegas, Eduardo ^a   Ferreira, Jorge ^b   Ortega, Arnaldo ^a  

^a UNIVERSIDAD DE TARAPACÁ   (Chile)

^b UNIVERSITY OF CHILE   (Chile)

Author keywords

AP 1; Early growth response gene; NF B; Nuclear factors; Prostate carcinoma; Soft agar assay

Indexed keywords

CISPLATIN; I KAPPA B; LUCIFERASE; PHORBOL 13 ACETATE 12 MYRISTATE; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR EGR 1;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; GENE ACTIVATION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PLASMID; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REPORTER GENE; SIGNAL TRANSDUCTION;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; CISPLATIN; EARLY GROWTH RESPONSE PROTEIN 1; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTRACELLULAR SPACE; MALE; NF-KAPPA B; PROSTATIC NEOPLASMS; PROTEIN TRANSPORT; TETRADECANOYLPHORBOL ACETATE; TRANSCRIPTION FACTOR AP-1;

EID: 79959952702     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2011.1047     Document Type: Article

References (50)

1. Eichelberger L, O Koch M, Eble J, Ulbright T, Juliar B and Cheng L: Maximum tumor diameter is an independent predictor of prostate-specific antigen recurrence in prostate cancer Mod Pathol 18: 886-890, 2005.
2. Virolle T, Krones-Herzig A, Baron V, Gregorio GG, Adamson ED and Mercola D: Egr1 promotes growth and survival of prostate cancer cells: identification of novel Egr1 target genes. Int J Biol Chem 278: 11802-11810, 2003. (Pubitemid 36800149)
3. Eid MA, Kumar MV, Iczkowski KA, Bostwick DG and Tindall DJ: Expression of early growth response genes in human prostate cancer. Int Cancer Res 58: 2461-2472, 1998.
4. Scharnhorst V, Menke AL and Attema J: EGR-1 enhances tumor growth and modulates the effect of the Wilms' tumor 1 gene products on tumorigenicity. Oncogene 19: 791-800, 2000. (Pubitemid 30107710)
5. Pignatelli M, Luna-Medina R, Perez-Rendon A, Santos A and Perez-Castillo A: The transcription factor early growth response factor-1 (EGR-1) promotes apoptosis of neuroblastoma cells. Int Biochem J 373: 739-746, 2003. (Pubitemid 36981083)
6. Houston P, Campbell CJ, Svaren J, Milbrandt J and Braddock M: The transcriptional corepressor NAB2 blocks Egr-1-mediated growth factor activation and agiogenesis. Int Biochem Communications 283: 480-486, 2001. (Pubitemid 32924716)
7. Collins S, Lutz MA, Zank PA, Anders R, Kersh G and Powell JD: Opposing regulation of T cell function by Egr-1/NAB2 and Egr-2 and Egr-3. Int Eur J Immunol 38: 528-536, 2008.
8. Amorino G, Hamilton V, Valerie K, Dent P, Lammering G and Schmidt-Ullrich R: Epidermal growth factor receptor dependence of radiation-induced transcription factor activation in human breast carcinoma cells. Int Mol Biol Cell 13: 2233-2244, 2002. (Pubitemid 34831329)
9. Adamson ED and Mercola D: Egr1 transcription factor, multiple roles in prostate tumor cell growth and survival. Tumour Biol 23: 93-102, 2002. (Pubitemid 34639111)
10. Banks MF, Gerasimovskaya EV, Tucker D, Frid MG, Carpenter TC and Stenmark KR: Egr-1 antisense oligonucleotide inhibit hypoxia-induced proliferation of pulmonary artery adventitial fibroblast. Int J Appl Physiol 98: 732-738, 2004. (Pubitemid 40129989)
11. White E: Life death, and the pursuit of apoptosis. Genes Dev 10: 1-15, 1996.
12. Nair P, Muthukkumar S, Sells SF, Han SS, Sukhatme VP and Rangnekar VM: Early growth response-1-dependent apoptosis is mediated by p53. J Biol Chem 272: 20131-20138, 1997. (Pubitemid 27340120)
13. Liu C, Rangnekar VM, Adamson E and Mercola D: Suppression of growth and transformation and induction of apoptosis by EGR-1. Cancer Gene Ther 5: 3-28, 1998. (Pubitemid 128639987)
14. Fahmy R, Dass C, Sun L, Chesterman C and Khachigian L: Transcription factor Egr-1 supports FGF-dependent angiogenesis during neovascularization and tumor growth. Nat Med 9: 1026-1032, 2003. (Pubitemid 37021782)
15. Svaren J, Ehrig T, Abdulkadir S, Ehrengruber M, Watson M and Milbrandt J: EGR1 target genes in prostate carcinoma cells identified by microarray analysis. J Biol Chem 275: 38524-38531, 2000. (Pubitemid 32009180)
16. Han S, Keum Y-S, Seo H-J and Surh Y-J: Curcumin suppresses activation of NF-κB and AP-1 induced by phorbol ester in cultured human promyelocytic leukemia cells. Biochem Mol Biol 35: 337-342, 2002. (Pubitemid 34655880)
17. Dhar A, Young MR and Colburn NH: The role of AP-1, NF-kappaB and ROS/NOS in skin carcinogenesis: the JB6 model is predictive. Mol Cell Biochem 234-235: 185-193, 2002.
18. Suzukawa K, Weber TJ and Colburn NH: AP-1, NF-kappa-B, and ERK activation thresholds for promotion of neoplastic transformation in the mouse epidermal JB6 model. Environ Health Perspect 110: 865-870, 2002.
19. Quantin B and Breathnach R: Epidermal growth factor stimulates transcription of the c-Jun protoncogene in rat fibroblasts. Nature 334: 538-539, 1988.
20. Goldgaber D, Harris H, Hla T, Maciag T, Donnelly R, Jacobsen J and Gajdusek D: Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells. Proc Natl Acad Sci USA 86: 7606-7610, 1989. (Pubitemid 19254505)
21. Karin M: The regulation of AP-1 activity by mitogen-activated protein kinases. J Biol Chem 270: 16483-16486, 1995.
22. Baeuerle PA and Henkel T: Function and activation of NF-κB in the immune system. Annu Rev Immunol 12: 141-179, 1994.
23. Blackwell TS and Christman JW: The role of nuclear factor-kappa B in cytokine gene regulation. Cell Mol Biol 17: 3-9, 1997. (Pubitemid 127500814)
24. Adcock IM: Transcription factors as activators of gene transcription: AP-1 and NF-kappa B. Monaldi Arch Chest Dis 52: 178-186, 1997.
25. Mueller J and Pahl H: Assaying NF-κB and AP-1 DNA-binding and transcriptional activity. Methods Mol Biol 99: 205-216, 2000.
26. Rupec RA and Baeuerle PA: The genomic response of tumor cells to hypoxia and reoxygenation: differential activation of transcription factors AP-1 and NF-κB. Eur J Biochem 234: 632-640, 1995.
27. Parra E and Ferreira J: The effect of siRNA-Egr-1 and camptothecin on growth and chemosensitivity of breast cancer cell lines. Oncol Rep 22: 1159-1165, 2010.
28. Parra E and Ferreira J: Knockdown of the c-Jun-N-terminal kinase expression by siRNA inhibits MCF-7 breast carcinoma cell lines growth. Oncol Rep 24: 1339-1345, 2010.
29. Parra E, Ortega A and Saenz L: Downregulation of Egr-1 by siRNA inhibits growth of human prostate carcinoma cell line PC-3. Oncol Rep 22: 1513-1518, 2009.
30. Inostroza J Saenz L, Calaf G, Cabello G and Parra E: Role of the phosphatase PP4 in the activation of JNK-1 in prostate carcinoma cell lines PC-3 and LNCaP resulting in increased AP-1 and EGR-1 activity. Biol Res 38: 163-178, 2005. (Pubitemid 41535617)
31. Parra E, McGuire K, Hedlund G and Dohlsten M: Overexpression of p65 and c-Jun substitutes for B7-1 costimulation by targeting the CD28RE within the IL-2 promoter. J Immunol 160: 5374-5381, 1998. (Pubitemid 28267826)
32. Parra E, Varga M, Hedlund G, Kalland T and Dohlsten M: Costimulation by B7-1 and LFA-3 targets distinct nuclear factors that bind to the interleukin-2 promoter: B7-1 negatively regulates LFA-3-induced NF-AT binding. Mol Cell Biol 17: 1314, 1997.
33. Aguilera C, Hoya-Arias R Haegeman G, Espinosa L and Bigas A: Recruitment of Ikappa B alpha to the hest 1 promoter is associated with transcriptional repression. Proc Natl Acad Sci USA 101: 16537-16542, 2004. (Pubitemid 39557748)
34. Zhou H, Lin A, Gu Z, Chen S, Park N and Chiu R: 12-O-tetrade- canoylphorbol-13-acetate (TPA)-induced c-Jun N-terminal kinase (JNK) phosphatase renders immortalized or transformed epithelial cells refractory to TPA-inducible JNK activity. J Biol Chem 275: 22868-22875, 2000. (Pubitemid 30646172)
35. Mohanty S, Huang J and Basu A: Enhancement of cisplatin sensitivity of cisplatin-resistant human cervical carcinoma cells by bryostatin 1. Clin Cancer Res 11: 6730-6737, 2005. (Pubitemid 41339016)
36. Lipshtat A, Purushothaman S, Iyengar R and Maayan A: Functions of bifans in context of multiple regulatory motifs in signaling networks. Biophys J 94: 2566-2579, 2008.
37. Sánchez I, Aznar S, Martínez M, Lacal J and Perona R: Cell stress and MEKK1-mediated c-Jun activation modulate NF-κB activity and cell viability. Mol Biol Cell 13: 2933-2945, 2002.
38. Angel P and Karin M: The role of Jun, Fos, and the AP-1 complex in cell proliferation and transformation. Biochem Biophys Acta 1072: 129-157, 1991.
39. Deng T and Karin M: JunB differs from c-Jun in its DNA-binding and dimerization domains, and represses c-Jun by formation of inactive heterodimers. Genes Dev 7: 479-490, 1993. (Pubitemid 23139240)
40. Wagner EF: AP-1-introductory remarks. Oncogene 20: 2334-2335, 2001.
41. Kawaida R, Ohtsuka T, Okutsu J, Takahashi T, Kadono Y, Oda H, Hikita A, Nakamura K, Tanaka S and Furukawa H: Jun dimerization protein 2 (JDP2), a member of the AP-1 family of transcription factor, mediates osteoclast differentiation induced by RANKL. J Exp Med 197: 1029-1035, 2003. (Pubitemid 36523200)
42. Heinrich R, Livne E, Ben-Izhak O and Aronheim A: The c-Jun dimerization protein 2 inhibits cell transformation and acts as a tumor suppressor gene. J Biol Chem 279: 5708-5715, 2004. (Pubitemid 38220600)
43. Esteve L, Haby C, Rodeau J, Humblot N, Aunis D and Zwiller J: Induction of c-fos, jun B and egr-1 expression by haloperidol in PC12 cells: involvement of calcium. Neuropharmacology 34: 439-448, 1995.
44. Morawietz H, Ma YH, Vives F, Wilson E, Sukhatme V, Holtz J and Ives H: Rapid induction and translocation of Egr-1 in response to mechanical strain in vascular smooth muscle cells. Circulation Res 84: 678-687, 1999. (Pubitemid 29157335)
45. Karin M and Delhase M: JNK or IKK, AP-1 or NF-kappaB, which are the targets for MEK kinase 1 action? Proc Natl Acad Sci USA 95: 9067-9079, 1998.
46. Chowdhury T, Salter DM, Bader DL and Lee DA: Signal transduction pathways involving p38 MAPK, JNK, NFκB and AP-1 influences the response of chondrocytes cultured in agarose constructs to IL-1β and dynamic compression. Inflamm Res 57: 306-313, 2008.
47. Min IM, Pietramaggiori G, Kim F, Passegué F, Stevenson K and Wagers A: The transcription factor EGR1 controls both the proliferation and localization of hematopoietic. Cell Stem Cell 4: 380-391, 2008. (Pubitemid 351455239)
48. Gottschalk A, Joseph L and Quintáns J: Differential induction of Egr-1 expression in WEHI-231 sublines does not correlate with apoptosis. Eur J Immunol 23: 2011-2015, 1993.
49. Boone D, Qi Y, Li Z and Hann S: Egr1 mediates p53-independent c-Myc-induced apoptosis via a noncanonical ARF-dependent transcriptional mechanism. Proc Natl Acad Sci USA 108: 2 632-637, 2011.
50. Zhang LS, Ma HW, Greyner HJ Zuo W and Mummert M: 1,2,3 inhibition of cell proliferation by CD44: Akt is inactivated and EGR-1 is down-regulated. Cell Prolif 43: 385-395, 2010.